SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-006129
Filing Date
2022-02-01
Accepted
2022-02-01 20:39:15
Documents
1
Period of Report
2022-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7602
  Complete submission text file 0001209191-22-006129.txt   9065
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SUTRO BIOPHARMA, INC. 310 UTAH AVE., SUITE 150 SOUTH SAN FRANCISCO CA 94080
Business Address
Vasquez Nicki (Reporting) CIK: 0001877585 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 22581079